SCHEMBL6942473

SCHEMBL6942473

C#CCOc1ccc(C(C)C(=O)O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 6/20 0.50
AKR1C2 P52895 5/20 0.50
PTGS2 P35354 9/20 0.49
PTGS1 P23219 6/20 0.47
TSHR P16473 3/20 0.47
LMNA P02545 2/20 0.47
CYP2C9 P11712 2/20 0.47
CXCR1 P25024 2/20 0.47
CXCR2 P25025 2/20 0.47
SLC22A6 Q4U2R8 2/20 0.47
ALB P02768 1/20 0.47
ESR1 P03372 1/20 0.47
ALOX5 P09917 1/20 0.47
RARB P10826 1/20 0.47
ADRB3 P13945 1/20 0.47
NFKB1 P19838 1/20 0.47
HTR2A P28223 1/20 0.47
NR1I3 Q14994 1/20 0.47
CXCL8 P10145 1/20 0.47
BLM P54132 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12765585 1.00 AKR1C3 (0.50) AKR1C3AKR1C2PTGS2PTGS1TSHR
SCHEMBL12765588 0.84 HPGD (0.45) PTGS2PTGS1GSTP1CA12CA1
SCHEMBL9427857 0.82 CA12 (0.46) PTGS2LMNACYP1A2GSTP1CA12
SCHEMBL9427853 0.82 CA12 (0.46) PTGS2LMNACYP1A2GSTP1CA12
SCHEMBL14037287 0.81 CA12 (0.49) PTGS2CYP2C9GSTP1CA12CA1
SCHEMBL10306543 0.81 CA12 (0.49) PTGS2CYP2C9GSTP1CA12CA1
SCHEMBL5881684 0.80 AKR1C3 (0.73) AKR1C3AKR1C2PTGS2PTGS1TSHR
SCHEMBL8507243 0.79 CA12 (0.49) PTGS2TSHRGSTP1CA12CA1
SCHEMBL10187829 0.79 GSTP1 (0.49) GSTP1CA12CA1CA2CA4
SCHEMBL16171931 0.78 PPARA (0.51) GSTP1CA12CA1CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1192170-B1 PROPARGYL PHENYL ETHER A2A RECEPTOR AGONISTS CV THERAPEUTICS INC (US) 2003-05-14 EP disclosed
US-6180615-B1 STIMULATE MAMMALIAN CORONARY VASODILATATION FOR THERAPEUTIC PURPOSES AND FOR PURPOSES OF IMAGING THE HEART CV THERAPEUTICS, INC. 2001-01-30 US disclosed